The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo.
Boitano S, Hoffman J, Flynn AN, Asiedu MN, Tillu DV, Zhang Z, Sherwood CL, Rivas CM, DeFea KA, Vagner J, Price TJ.
Boitano S, et al. Among authors: vagner j.
Br J Pharmacol. 2015 Sep;172(18):4535-4545. doi: 10.1111/bph.13238. Epub 2015 Aug 3.
Br J Pharmacol. 2015.
PMID: 26140338
Free PMC article.